7420
P.-Y. Lu et al. / Tetrahedron 65 (2009) 7415–7421
2H, 2ꢂCH), 7.07–7.13 (m, 4H, ArH), 7.23–7.32 (m, 6H, ArH); 13C NMR
1.21 (s, 3H, CH3), 1.90 (dd, J¼13.5, 11.1 Hz, 1H, CH), 1.99 (dd, J¼13.5,
9.1 Hz, 1H, CH), 2.10–2.25 (m, 2H, 2ꢂCH), 3.09 (dd, J¼11.6, 8.6 Hz,
1H, CH), 3.72 (dd, J¼4.5, 1.6 Hz, 1H, CH), 3.98 (dd, J¼11.1, 9.1 Hz, 1H,
CH), 4.89 (br s, 1H, NH), 6.61 (dd, J¼7.7, 1.2 Hz, 2H, ArH), 6.68 (t,
J¼7.7 Hz, 1H, ArH), 6.81 (dd, J¼7.7, 1.2 Hz, 2H, ArH), 6.98–7.11 (m,
7H, ArH), 7.27–7.34 (m, 3H, ArH); 13C NMR (75.4 MHz, CDCl3)
(75.4 MHz, CDCl3) d 29.0, 34.8, 47.3, 104.0, 127.2, 127.8, 128.9, 135.3,
137.8, 145.3, 151.1, 183.3, 184.9. Anal. Calcd for C34H36N2O4: C, 76.09;
H, 6.76; N, 5.22. Found: C, 75.76; H, 6.75; N, 5.11.
3.3.7. 2,20-Bi(5,6-dimethyl-3-phenylamino-1,4-benzoquinone) 9c
Dark red powder; mp 235–236 ꢀC; IR (KBr) 3360, 3305, 1635,
d 11.6, 12.7, 31.0, 37.6, 46.8, 48.1, 51.9, 53.8, 57.2, 70.1, 115.2, 118.2,
1580, 1310 cmꢁ1
;
1H NMR (400 MHz, CDCl3)
d
1.82 (s, 6H, 2ꢂCH3),
127.1, 127.7, 127.8, 128.3, 128.72, 128.74, 128.9, 138.4, 139.0, 144.2,
214.6, 216.1. Anal. Calcd for C30H29NO2: C, 82.73; H, 6.71; N, 3.22.
Found: C, 82.81; H, 6.82; N, 3.15.
2.01 (s, 6H, 2ꢂCH3), 6.84 (d, J¼7.5 Hz, 4H, ArH), 6.96 (t, J¼7.5 Hz, 2H,
ArH), 7.01 (br s, 2H, 2ꢂNH), 7.05 (t, J¼7.5 Hz, 4H, ArH); 13C NMR
(75.4 MHz, CDCl3) d 11.6, 12.9, 108.4, 123.9, 124.9, 127.8, 135.9, 137.8,
139.2, 144.0, 183.2, 184.1. Anal. Calcd for C28H24N2O4: C, 74.32; H,
5.35; N, 6.19. Found: C, 74.12; H, 5.33; N, 6.17.
3.4.4. rel-(1R,3S,4S,6S,10R)-1,6-Dimethyl-3-(2-methylphenyl-
amino)-4,10-diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17d
White crystals; mp 249–250 ꢀC; IR (KBr) 3400, 2945, 1725, 1605,
3.4. Typical experimental procedure for the radical
annulation reaction
1455 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 0.83 (s, 3H, CH3), 1.22 (s,
3H, CH3), 1.78 (s, 3H, CH3), 1.91 (dd, J¼13.5, 11.1 Hz, 1H, CH), 2.00
(dd, J¼13.5, 9.2 Hz, 1H, CH), 2.13–2.28 (m, 2H, 2ꢂCH), 3.11 (dd,
J¼11.5, 8.7 Hz, 1H, CH), 3.78 (dd, J¼4.3, 1.4 Hz, 1H, CH), 4.02 (dd,
J¼11.1, 9.2 Hz,1H, CH), 4.87 (br s,1H, NH), 6.63 (t, J¼7.5 Hz,1H, ArH),
6.73 (d, J¼7.5 Hz, 2H, ArH), 6.84 (d, J¼7.5 Hz, 1H, ArH), 6.94 (d,
J¼8.0 Hz, 1H, ArH), 6.97–7.03 (m, 2H, ArH), 7.03–7.11 (m, 4H, ArH),
A mixture of 2,3-dimethyl-5-(3,5-dimethylphenylamino)-1,4-
benzoquinone (1a, 151 mg, 0.59 mmol), styrene (1.29 g,
12.4 mmol), isopropanol (2 mL), and manganese(III) acetate
(395 mg, 1.47 mmol) in acetonitrile (8 mL) was heated at 70 ꢀC.
After heated for 3 h, the color of manganese(III) acetate dis-
appeared, another manganese(III) acetate (405 mg, 1.51 mmol)
was added. The reaction mixture was heated for another 4 h and
then diluted with ethyl acetate (100 mL), washed with saturated
aqueous sodium bisulfite (50 mL), water (2ꢂ50 mL), and dried
(Na2SO4). The solvent was evaporated under reduced pressure and
the crude product was purified by column chromatography over
silica gel (20 g) using ethyl acetate–hexane (1:20) as eluent, fol-
lowed by crystallization (ethyl acetate–hexane) to give 17a
(105 mg, 38%).
7.27–7.37 (m, 3H, ArH); 13C NMR (75.4 MHz, CDCl3)
d 11.6, 12.7, 17.2,
31.0, 37.6, 46.3, 48.1, 52.5, 53.8, 57.1, 70.4, 113.0, 118.1, 124.3, 126.3,
127.0, 127.6, 127.7, 128.3, 128.68, 128.71, 130.4, 138.2, 139.0, 142.5,
215.0, 216.3. Anal. Calcd for C31H31NO2: C, 82.82; H, 6.95; N, 3.12.
Found: C, 83.05; H, 7.10; N, 3.07.
3.4.5. rel-(1R,3S,4S,6S,10R)-1,6-Dimethyl-3-(2,4-dimethylphenyl-
amino)-4,10-diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17e
White crystals; mp 257–258 ꢀC; IR (KBr) 3390, 2925, 1730, 1515,
1455 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 0.82 (s, 3H, CH3), 1.21 (s,
3H, CH3), 1.74 (s, 3H, CH3), 1.90 (dd, J¼13.5,11.1 Hz,1H, CH), 1.99 (dd,
J¼13.5, 9.2 Hz, 1H, CH), 2.12–2.25 (m, 2H, 2ꢂCH), 2.19 (s, 3H, CH3),
3.09 (dd, J¼11.4, 8.8 Hz,1H, CH), 3.75 (dd, J¼4.2,1.9 Hz,1H, CH), 3.99
(dd, J¼11.1, 9.2 Hz, 1H, CH), 4.72 (s, 1H, NH), 6.67 (s, 1H, ArH), 6.73
(d, J¼7.2 Hz, 2H, ArH), 6.80–6.88 (m, 2H, ArH), 6.97–7.10 (m, 5H,
3.4.1. rel-(1R,3S,4S,6S,8S,10R)-1,6-Dimethyl-3-(3,5-dimethylphenyl-
amino)-4,10-diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17a
White crystals; mp 222–223 ꢀC; IR (KBr) 3375, 2950, 1725, 1605,
1455 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 0.80 (s, 3H, CH3), 1.21 (s,
3H, CH3), 1.89 (dd, J¼13.5, 11.1 Hz, 1H, CH), 1.98 (dd, J¼13.5, 9.2 Hz,
1H, CH), 2.08–2.23 (m, 2H, 2ꢂCH), 2.17 (s, 6H, 2ꢂCH3), 3.08 (dd,
J¼11.7, 8.5 Hz, 1H, CH), 3.72 (dd, J¼4.4, 1.2 Hz, 1H, CH), 3.95 (dd,
J¼11.1, 9.2 Hz, 1H, CH), 4.77 (s, 1H, NH), 6.23 (s, 2H, ArH), 6.34 (s, 1H,
ArH), 6.82 (dd, J¼7.6, 1.7 Hz, 2H, ArH), 7.00–7.13 (m, 5H, ArH), 7.27–
ArH), 7.25–7.35 (m, 3H, ArH); 13C NMR (75.4 MHz, CDCl3)
d 11.6,
12.7,17.2, 20.3, 31.0, 37.6, 46.5, 48.1, 52.5, 53.8, 57.1, 70.5,113.1,124.4,
126.5, 127.0, 127.2, 127.6, 127.7, 128.3, 128.7, 131.2, 138.3, 139.1, 139.9,
215.1, 216.4. Anal. Calcd for C32H33NO2: C, 82.90; H, 7.17; N, 3.02.
Found: C, 82.73; H, 7.18; N, 2.95.
7.34 (m, 3H, ArH); 13C NMR (75.4 MHz, CDCl3)
d 11.6, 12.7, 21.4, 31.1,
37.6, 47.1, 48.1, 51.8, 53.8, 57.2, 70.2, 113.5, 120.3, 127.0, 127.7, 127.8,
128.3, 128.7, 138.5, 138.6, 139.0, 144.1, 214.6, 216.4. Anal. Calcd for
C32H33NO2: C, 82.90; H, 7.17; N, 3.02. Found: C, 82.81; H, 7.21; N,
3.00.
3.4.6. rel-(1R,3S,4S,6S,10R)-3-(4-Bromophenylamino)-1,6-
dimethyl-4,10-diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17f
White crystals; mp 251–252 ꢀC; IR (KBr) 3385, 2970, 1730, 1595,
1455 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 0.81 (s, 3H, CH3), 1.21 (s,
3H, CH3), 1.89 (dd, J¼13.4, 11.2 Hz, 1H, CH), 1.98 (dd, J¼13.4, 9.2 Hz,
1H, CH), 2.06–2.24 (m, 2H, 2ꢂCH), 3.09 (dd, J¼11.7, 8.4 Hz, 1H, CH),
3.63 (d, J¼3.8 Hz, 1H, CH), 3.92 (dd, J¼11.2, 9.2 Hz, 1H, CH), 4.94 (br
s, 1H, NH), 6.48 (d, J¼7.9 Hz, 2H, ArH), 6.80 (d, J¼7.9 Hz, 2H, ArH),
6.99–7.16 (m, 7H, ArH), 7.23–7.34 (m, 3H, ArH); 13C NMR (75.4 MHz,
3.4.2. rel-(1R,3S,4S,6S,10R)-1,6-Dimethyl-3-(4-methylphenyl-
amino)-4,10-diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17b
White powder; mp 201–202 ꢀC; IR (KBr) 3390, 2935, 1730, 1615,
1455 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 0.80 (s, 3H, CH3), 1.21 (s,
3H, CH3), 1.89 (dd, J¼13.5, 11.1 Hz, 1H, CH), 1.98 (dd, J¼13.5, 9.1 Hz,
1H, CH), 2.09–2.24 (m, 2H, 2ꢂCH), 2.20 (s, 3H, CH3), 3.08 (dd, J¼11.6,
8.6 Hz, 1H, CH), 3.70 (dd, J¼4.5, 1.6 Hz, 1H, CH), 3.94 (dd, J¼11.1,
9.1 Hz, 1H, CH), 6.52 (d, J¼8.4 Hz, 2H, ArH), 6.82 (dd, J¼7.8, 1.4 Hz,
2H, ArH), 6.86 (d, J¼8.4 Hz, 2H, ArH), 6.99–7.12 (m, 5H, ArH), 7.24–
CDCl3) d 11.6, 12.7, 30.9, 37.6, 46.8, 48.0, 51.7, 53.7, 57.2, 69.9, 110.1,
116.7,127.3,127.8,128.0,128.3,128.6,128.7,131.7,138.2, 138.8, 143.3,
214.3, 215.7. Anal. Calcd for C30H28BrNO2: C, 70.04; H, 5.49; N, 2.72.
Found: C, 69.89; H, 5.42; N, 2.63.
7.34 (m, 3H, ArH); 13C NMR (75.4 MHz, CDCl3)
d
11.5, 12.7, 20.3, 30.9,
3.4.7. rel-(1R,3S,4S,6S,10R)-3-(4-Chlorophenylamino)-1,6-
dimethyl-4,10-diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17g
White crystals; mp 241–242 ꢀC; IR (KBr) 3395, 2975, 1730, 1600,
37.6, 46.9, 48.0, 51.8, 53.7, 57.2, 70.2, 115.4, 127.0, 127.4, 127.6, 127.8,
128.2, 128.7, 129.4, 138.5, 139.0, 141.6, 214.6, 216.2. Anal. Calcd for
C31H31NO2: C, 82.82; H, 6.95; N, 3.12. Found: C, 82.80; H, 6.98; N,
3.06.
1500 cmꢁ1 1H NMR (400 MHz, CDCl3)
; d 0.81 (s, 3H, CH3), 1.21 (s,
3H, CH3), 1.88 (dd, J¼13.5, 11.2 Hz, 1H, CH), 1.99 (dd, J¼13.5, 9.1 Hz,
1H, CH), 2.03–2.26 (m, 2H, 2ꢂCH), 3.09 (dd, J¼11.7, 8.4 Hz, 1H, CH),
3.63 (dd, J¼4.0,1.2 Hz,1H, CH), 3.91 (dd, J¼11.2, 9.1 Hz,1H, CH), 4.93
(br s, 1H, NH), 6.52 (d, J¼8.8 Hz, 2H, ArH), 6.79 (dd, J¼7.7, 1.4 Hz, 2H,
ArH), 6.97–7.15 (m, 7H, ArH), 7.28–7.36 (m, 3H, ArH); 13C NMR
3.4.3. rel-(1R,3S,4S,6S,10R)-1,6-Dimethyl-3-phenylamino-4,10-
diphenyl-tricyclo[4,4,0,03,8]decane-2,7-dione 17c
White crystals; mp 204–205 ꢀC; IR (KBr) 3380, 2970, 1730,
1600, 1455 cmꢁ1
;
1H NMR (400 MHz, CDCl3)
d
0.81 (s, 3H, CH3),
(75.4 MHz, CDCl3) d 11.6, 12.7, 30.9, 37.6, 46.8, 48.0, 51.8, 53.7, 57.2,